BioVersys AG
No trades
About BioVersys AG
Sector
Industry
Website
Headquarters
Basel
Founded
2008
IPO date
Feb 7, 2025
IPO offer price
39.71 USD
Identifiers
2
ISIN CH0210362643
BioVersys AG is a clinical stage biopharmaceutical company, which engages in identifying, development, and commercializing novel antibacterial products for infections caused by multi-drug resistant (MDR) bacteria. It is involved in the research and development programs that address nosocomial infections of Acinetobacter baumannii and tuberculosis. The company was founded by Marc Gitzinger and Marcel Tigges on September 24, 2008 and is headquartered in Basel, Switzerland.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BIOV is 23.2 CHF — it has decreased by −3.73% in the past 24 hours. Watch BioVersys AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange BioVersys AG stocks are traded under the ticker BIOV.
BIOV stock has fallen by −4.92% compared to the previous week, the month change is a −8.30% fall, over the last year BioVersys AG has showed a −36.44% decrease.
We've gathered analysts' opinions on BioVersys AG future price: according to them, BIOV price has a max estimate of 70.00 CHF and a min estimate of 38.00 CHF. Watch BIOV chart and read a more detailed BioVersys AG stock forecast: see what analysts think of BioVersys AG and suggest that you do with its stocks.
BIOV reached its all-time high on Feb 7, 2025 with the price of 37.0 CHF, and its all-time low was 21.2 CHF and was reached on Nov 28, 2025. View more price dynamics on BIOV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BIOV stock is 5.22% volatile and has beta coefficient of −0.30. Track BioVersys AG stock price on the chart and check out the list of the most volatile stocks — is BioVersys AG there?
Yes, you can track BioVersys AG financials in yearly and quarterly reports right on TradingView.
No, BIOV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIOV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioVersys AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioVersys AG technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioVersys AG stock shows the sell signal. See more of BioVersys AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.